Anika Therapeutics Inc. (ANIK): Price and Financial Metrics


Anika Therapeutics Inc. (ANIK): $30.07

-0.59 (-1.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ANIK to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ANIK POWR Grades

  • ANIK scores best on the Value dimension, with a Value rank ahead of 76.65% of US stocks.
  • The strongest trend for ANIK is in Growth, which has been heading up over the past 177 days.
  • ANIK's current lowest rank is in the Sentiment metric (where it is better than 21.08% of US stocks).

ANIK Stock Summary

  • The price/operating cash flow metric for ANIKA THERAPEUTICS INC is higher than 91.6% of stocks in our set with a positive cash flow.
  • ANIK's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 14.35% of US stocks.
  • Over the past twelve months, ANIK has reported earnings growth of 246.98%, putting it ahead of 93.44% of US stocks in our set.
  • Stocks that are quantitatively similar to ANIK, based on their financial statements, market capitalization, and price volatility, are FORG, RCEL, DDD, FLYW, and WEAV.
  • ANIK's SEC filings can be seen here. And to visit ANIKA THERAPEUTICS INC's official web site, go to www.anikatherapeutics.com.

ANIK Valuation Summary

  • ANIK's EV/EBIT ratio is -18.3; this is 284.85% lower than that of the median Healthcare stock.
  • ANIK's price/sales ratio has moved up 2.2 over the prior 243 months.

Below are key valuation metrics over time for ANIK.

Stock Date P/S P/B P/E EV/EBIT
ANIK 2023-01-20 3.0 1.6 -28.7 -18.3
ANIK 2023-01-19 2.9 1.6 -28.2 -17.9
ANIK 2023-01-18 2.9 1.6 -28.3 -18.0
ANIK 2023-01-17 3.0 1.6 -28.9 -18.4
ANIK 2023-01-13 3.0 1.6 -28.8 -18.4
ANIK 2023-01-12 3.0 1.6 -28.9 -18.4

ANIK Growth Metrics

    Its 2 year cash and equivalents growth rate is now at 37.2%.
  • Its 5 year revenue growth rate is now at 19.91%.
  • The year over year net income to common stockholders growth rate now stands at 93.92%.
ANIK's revenue has moved up $27,151,000 over the prior 30 months.

The table below shows ANIK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 152.435 8.4 -15.744
2022-06-30 151.707 7.753 -11.011
2022-03-31 150.195 8.959 -1.637
2021-12-31 147.794 8.397 4.134
2021-09-30 144.661 6.512 -5.729
2021-06-30 136.819 10.315 -12.698

ANIK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANIK has a Quality Grade of B, ranking ahead of 75.55% of graded US stocks.
  • ANIK's asset turnover comes in at 0.363 -- ranking 122nd of 186 Medical Equipment stocks.
  • SYK, EYE, and ISRG are the stocks whose asset turnover ratios are most correlated with ANIK.

The table below shows ANIK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.363 0.555 -0.097
2021-03-31 0.326 0.532 -0.187
2020-12-31 0.322 0.529 -0.144
2020-12-31 0.322 0.529 -0.144
2020-09-30 0.322 0.576 -0.027
2020-06-30 0.337 0.636 0.076

ANIK Price Target

For more insight on analysts targets of ANIK, see our ANIK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $49.67 Average Broker Recommendation 1.33 (Strong Buy)

ANIK Stock Price Chart Interactive Chart >

Price chart for ANIK

ANIK Price/Volume Stats

Current price $30.07 52-week high $33.18
Prev. close $30.66 52-week low $19.95
Day low $30.03 Volume 66,405
Day high $30.76 Avg. volume 72,279
50-day MA $30.15 Dividend yield N/A
200-day MA $25.16 Market Cap 439.32M

Anika Therapeutics Inc. (ANIK) Company Bio


Anika Therapeutics develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. The company was founded in 1983 and is based in Bedford, Massachusetts.


ANIK Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIK Latest Social Stream


Loading social stream, please wait...

View Full ANIK Social Stream

Latest ANIK News From Around the Web

Below are the latest news stories about ANIKA THERAPEUTICS INC that investors may wish to consider to help them evaluate ANIK as an investment opportunity.

Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?

Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.

Yahoo | January 17, 2023

Biogen (BIIB), Eisai's Lecanemab Gets FDA Nod for Alzheimer's

FDA approves Biogen (BIIB) and Eisai's lecanemab on an accelerated basis. Eisai filed a supplemental biologics license application (sBLA) to the FDA to get a traditional approval for Leqembi.

Yahoo | January 9, 2023

Multiple insiders bought Anika Therapeutics, Inc. (NASDAQ:ANIK) stock earlier this year, a positive sign for shareholders

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | December 28, 2022

Medical Aesthetics Global Market Report 2022: Ukraine-Russia War Impact

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- AbbVie Inc, Medytox Inc, Galderma S. A., Alma Lasers Ltd, Merz Pharma GmbH and Co KGaA, Cynosure LLC, Fotona d.o.o., Anika Therapeutics Inc., Johnson & Johnson, Cutera Inc, Solta Medical International Inc, Quanta System SpA, Sisram Medical Ltd.,…

PR Newswire | December 12, 2022

Companies - Anika Therapeutics, Inc. Expected to Post FY2022 Earnings of Per Share

Anika Therapeutics, Inc. - Barrington Research upped their FY2022 earnings per share estimates for shares of Anika Therapeutics in a report released on Wednesday, November 9th…

Business Mag | November 14, 2022

Read More 'ANIK' Stories Here

ANIK Price Returns

1-mo 1.59%
3-mo 0.13%
6-mo 21.84%
1-year -3.96%
3-year -26.85%
5-year -54.93%
YTD 1.59%
2022 -17.39%
2021 -20.84%
2020 -12.71%
2019 54.27%
2018 -37.66%

Continue Researching ANIK

Here are a few links from around the web to help you further your research on Anika Therapeutics Inc's stock as an investment opportunity:

Anika Therapeutics Inc (ANIK) Stock Price | Nasdaq
Anika Therapeutics Inc (ANIK) Stock Quote, History and News - Yahoo Finance
Anika Therapeutics Inc (ANIK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8955 seconds.